canceldeath
Registry update — unassessed

Efficacy of a Single Dose of Nicotinamide Riboside (NR) on Sleep: A Randomized Controlled Study

Trial registry update: COMPLETED. No results reported in the supplied registry record.

RCTN=28Minor significance
Reporter brief

What this changes

The finding has not established an approved change to our evidence assessment.

Source date: Sep 16, 2026 · Discovered: Sep 23, 2026 · Assessed: — · Research update

What it does not prove

  • Whether a single dose of nicotinamide riboside affects N3 sleep or other sleep parameters, since no results are reported in the abstract
  • Whether the intervention would have effects with repeated dosing or in populations with clinical sleep disorders
  • The mechanism by which NAD+ precursors might influence sleep regulation, as this study examined only acute effects

Extracted from supplied source material; model confidence is not a measured probability of correctness.

Design
Rct
Sample size
28
Duration
—
Population
Healthy adults who report mild sleep difficulties
Primary outcome
Change in N3 sleep duration from the baseline night to the intervention night
Effect size
—
Significance
Not reported
Journal
Eye & ENT Hospital of Fudan University
Published
Sep 16, 2026

Recorded source passages

Abstract or registry material supplied for assessment; source version 1. This is not a claim of full-text review.

This randomized, double-blind, placebo-controlled study, 28 healthy adults will complete two overnight sleep assessments using polysomnography (PSG)
After a baseline night of sleep recording, participants will receive either NR or a placebo before bedtime on the second night
The primary outcome is the change in N3 sleep duration from the baseline night to the intervention night

Assessment history

One thread per scientific event, no matter how many outlets covered it.

Sign in to join the discussion.

No comments yet

Be the first to weigh in on this evidence.